These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33994188)

  • 1. Borderline Changes in Renal Transplantation: Are We Aware of the Real Impact in Graft Survival?
    Figueiredo AC; Leal R; Mira F; Pardinhas C; Rodrigues L; Marques MG; Santos L; Romãozinho C; Sá H; Figueiredo A; Alves R
    Transplant Proc; 2021 Jun; 53(5):1514-1518. PubMed ID: 33994188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Artif Organs; 2017 Apr; 41(4):381-391. PubMed ID: 27653963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 6-month protocol renal biopsy under modern immunosuppression.
    Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
    Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline rejection: To treat or not to treat?
    Palmisano A; D'Angelo M; Gandolfini I; Delsante M; Rossi GM; Gentile M; Fiaccadori E; Cravedi P; Maggiore U
    Transpl Immunol; 2024 Jun; 84():102047. PubMed ID: 38641147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Pathological Analyses of Borderline Changes Cases after Kidney Transplantation.
    Shimizu T
    Nephron; 2020; 144 Suppl 1():91-96. PubMed ID: 33221807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
    Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Aguilar-Sandoval E; De la Paz-Román M; Soto-Miranda E; Rivera-Sanchez Y; Martínez-Maldonado M
    Transplant Proc; 2021 Apr; 53(3):1005-1009. PubMed ID: 32178925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes.
    Sousa MV; Zollner RL; Mazzali M
    J Bras Nefrol; 2019 Sep; 42(2):201-210. PubMed ID: 31528982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients.
    Sethi S; Najjar R; Peng A; Choi J; Lim K; Vo A; Jordan SC; Huang E
    Transplantation; 2020 Jul; 104(7):1500-1507. PubMed ID: 31568398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-Year Analyses of Renal Graft Biopsies: A Single-Center Pathology Experience.
    Canpolat T; Ozdemir BH; Torun D; Caliskan K; Haberal M
    Exp Clin Transplant; 2017 Apr; 15(2):171-178. PubMed ID: 27099951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Subclinical Rejection on Kidney Graft Function.
    Tugmen C; Sert I; Kebapci E; Tasli F; Karadeniz T; Avci EK; Tuncer K; Ayna TK; Tanrisev M; Olmez M; Karaca C
    Transplant Proc; 2019 Dec; 51(10):3304-3308. PubMed ID: 31732212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome.
    Valente M; Furian L; Marchini F; Marino S; Cardillo M; Rigotti P; Aiello FB
    Transplant Proc; 2010; 42(6):2214-7. PubMed ID: 20692447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Isolated V1 Arteritis in Renal Transplantation.
    Mikhail D; Chan E; Sharma H; Kleinsteuber D; Wei J; Rim C; Henein M; Sener A; Jevnikar AM; Gabril M; Moussa M; Luke PP
    Transplant Proc; 2021 Jun; 53(5):1570-1575. PubMed ID: 33994184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
    Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
    Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
    Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M
    Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.